Omaha, NE, United States of America

Kyle Rhoden


Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Kyle Rhoden

Introduction

Kyle Rhoden is an accomplished inventor based in Omaha, NE (US). He has made significant contributions to the field of biotechnology, particularly in the area of pathogen detection. With a total of 2 patents, his work focuses on enhancing the accuracy and efficiency of diagnostic processes.

Latest Patents

Rhoden's latest patents include systems and processes for distinguishing pathogenic and non-pathogenic sequences from specimens. These innovations involve fully-automated next-generation sequencing platforms designed for the detection of target specimens, such as SARS-CoV-2. His patented processes enable the differentiation between infectious and non-infectious signals from specimens. The analysis provided by these systems can facilitate simultaneous diagnosis and genomic surveillance of multiple distinct specimens. This technology is crucial for informing the status of a subject or location regarding infectivity.

Career Highlights

Kyle Rhoden is currently employed at Clear Labs, Inc., where he continues to develop groundbreaking technologies in the field of diagnostics. His work is instrumental in advancing public health initiatives and improving the accuracy of pathogen detection.

Collaborations

Rhoden collaborates with talented professionals in his field, including Sasan Amini and Ramin Khaksar. These partnerships enhance the innovative capabilities of his projects and contribute to the overall success of their initiatives.

Conclusion

Kyle Rhoden's contributions to biotechnology through his patents and work at Clear Labs, Inc. highlight his commitment to improving diagnostic processes. His innovations play a vital role in public health and pathogen detection.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…